Lattice Biologics Ltd. (LBLTF)

Lattice Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 2, 2025	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Market Capitalization	0	5	2	3	8	10
Market Cap Growth	-99.99%	180.45%	-48.14%	-57.78%	-20.07%	-
Enterprise Value	-	8	4	6	10	14
Last Close Price	0.00	0.04	0.02	0.03	0.08	0.15
PS Ratio	0.00	1.93	0.77	2.82	2.82	2.56
PB Ratio	0.00	-0.74	-0.27	-0.61	-1.81	-1.64
P/FCF Ratio	-	-	15.43	97.94	-	-
P/OCF Ratio	-	8.85	10.47	12.35	-	-
EV/Sales Ratio	-	3.14	1.72	5.01	3.73	3.65
EV/FCF Ratio	-	-	34.42	173.82	-	-
Debt / Equity Ratio	-	-0.49	-0.34	-0.38	-0.56	-0.50
Debt / EBITDA Ratio	-	69.62	-	-	-	-
Debt / FCF Ratio	-	-	19.43	60.81	-	-
Net Debt / Equity Ratio	-	-0.48	-0.33	-0.38	-0.56	-0.49
Net Debt / EBITDA Ratio	-	-51.08	-5.54	-1.57	-0.92	-0.67
Net Debt / FCF Ratio	-	-55.03	19.29	60.62	-3.08	-1.33
Asset Turnover	1.01	0.93	0.82	0.36	0.68	0.71
Inventory Turnover	-	2.10	1.09	0.34	1.04	1.12
Quick Ratio	-	0.04	0.04	0.03	0.04	0.06
Current Ratio	-	0.12	0.14	0.24	0.32	0.36
Return on Assets (ROA)	-24.95%	-7.93%	-13.70%	-28.48%	-43.63%	-56.95%
Return on Capital Employed (ROCE)	-611.20%	7.00%	10.80%	38.00%	91.40%	152.50%
Earnings Yield	-743478.91%	-31.25%	-59.82%	-37.74%	-19.74%	-81.25%
FCF Yield	-546717.19%	-1.18%	6.48%	1.02%	-10.03%	-22.57%
Buyback Yield / Dilution	-33.86%	-9.76%	-0.00%	-19.82%	-61.99%	-82.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.